Five Prime Therapeutics to Present at Two Upcoming Healthcare Conferences
Get Alerts FPRX Hot Sheet
Join SI Premium – FREE
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics today announced that Aron Knickerbocker, Chief Executive Officer, is scheduled to present at the following two investor conferences:
- The Jefferies Healthcare Conference, on Thursday, June 6th at 9:30am ET / 6:30am PT
- The 40th Annual Goldman Sachs Global Healthcare Conference on Wednesday, June 12th at 1:00pm ET / 10:00am PT
The presentations will be webcast and may be accessed at the âEvents & Presentationsâ section of the Companyâs website at: http://investor.fiveprime.com/events.cfm. Five Prime will maintain an archived replay of the webcast on its website for 30 days after the conference.
About Five Prime
Five Prime Therapeutics, Inc. discovers and develops innovative protein therapeutics to improve the lives of patients with serious diseases. Five Primeâs product candidates have innovative mechanisms of action and address patient populations in need of better therapies. The company focuses on researching and developing immuno-oncology and targeted cancer therapies paired with companion diagnostics to identify patients who are most likely to benefit from treatment with Five Primeâs product candidates. Five Prime has entered into strategic collaborations with leading global pharmaceutical companies and has promising product candidates in clinical and preclinical development. For more information, please visit www.fiveprime.com or follow us on LinkedIn, Twitter and Facebook.
Source: Five Prime Therapeutics, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190524005408/en/
Media and Investor Contact
Martin Forrest
VP, Investor
Relations & Corporate Communications
Five Prime Therapeutics,
Inc.
415-365-5625
[email protected]
Source: Five Prime Therapeutics, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Argo Graphene names battery scientist Al-Hallaj to board
- Jeen Brings Real-Time Cost Control to Enterprise AI
- Skyven Arcturus Heat Pump Achieves COP of 8.0, Marking A New Level of Industrial Steam Efficiency
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Goldman Sachs, Jefferies & Co, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share